Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Mary E. Rosandich"'
Autor:
Thomas B. Campbell, Alan L. Landay, Daniel R. Ambruso, Daniel R. Kuritzkes, Robert T. Schooley, Roger J. Pomerantz, Steve Miles, Jeannette Mladenovic, Gregory C. Peterson, Robert W. Coombs, Roberta J. Wong, Mary E. Rosandich, Anne Sevin
Publikováno v:
Blood. 95:48-55
Genetic modification of hemopoietic progenitor cells ex vivo, followed by the infusion of the genetically modified cells into the human immunodeficiency virus-1 (HIV-1) infected donor, has been proposed as a treatment for HIV-1 infection. The current
Autor:
Kenneth Fife, Dawn Bell, Janine Maenza, Margaret A. Fischl, Roland L. Bassett, Ian C. Marschner, Joseph J. Eron, Victoria A. Johnson, Daniel R. Kuritzkes, Robert L. Murphy, Caria Pettinelli, Ken Wood, Mary E. Rosandich, Jean Pierre Sommadossi
Publikováno v:
AIDS. 13:685-694
Objective: To study the antiviral activity of lamivudine (3TC) plus zidovudine (ZDV), didanosine (ddl), or stavudine (d4T). Design: Randomized, placebo-controlled, partially double-blinded multicenter study. Setting: Adult AIDS Clinical Trials Units.
Autor:
Michael H. Allen, Mary E. Rosandich, Daniel R. Kuritzkes, Rebekah Ja Gass, Russell K. Young, Dave Shugarts
Publikováno v:
Antiviral Therapy. 3:97-102
Susceptibility to zidovudine and lamivudine was determined on human immunodeficiency virus type 1 (HIV-1) isolates obtained from patients who added lamivudine after 6 months of treatment with zidovudine. Lamivudine-resistant isolates that were also z
Autor:
Ferdinand Messari, James O. Kahn, Thomas B. Campbell, Terrence F. Blaschke, Robert T. Schooley, Daniel S. Stein, John P. Phair, Ann C. Collier, Mary E. Rosandich, Daniel R. Kuritzkes, John C. Pottage
Publikováno v:
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 12:363-370
We performed a pilot study that examined the clinical and pharmacokinetic interactions between zidovudine (ZDV) and a pyridinone derivative, L-697-661. The results indicate that the drugs were well tolerated, with no important pharmacokinetic interac
Autor:
Robert T. Schooley, Tyler J. Curiel, Daniel R. Kuritzkes, Elizabeth J. McFarland, David J. Schoen, Mary E. Rosandich
Publikováno v:
Journal of Infectious Diseases. 167:719-7263
Cytotoxic T lymphocytes (CTL) specific for human immunodeficiency virus type 1 (HIV-1) are thought to play an important role in controlling HIV-1 infection. HIV-1-specific CTL are readily demonstrated in unstimulated peripheral blood mononuclear cell
Autor:
Lance S. Terada, Irene R. Willingham, Jonathan A. Leff, John E. Repine, Glenn W. Kindt, Mary E. Rosandich
Publikováno v:
Journal of Cellular Physiology. 148:191-196
Bovine brain endothelial cells (EC) that were isolated and propagated in pure culture had increased (greater than 20-fold) levels of xanthine oxidase and xanthine dehydrogenase activity compared to whole brain homogenate. Brain EC also released super
Autor:
James O. Kahn, Patrick Haslett, Martin S. Hirsch, Daniel R. Kuritzkes, Bruce D. Walker, Mary E. Rosandich, Ronald T. Mitsuyasu, M. Juliana McElrath, Robert T. Schooley, Elizabeth L. Cooney, Thomas C. Merigan, Simon Chiu, Gerald Friedland, Dawn Bell, Bin Zhang, David Chernoff, Gayle Jones, Ann C. Collier, Smriti K. Kundu, Thomas Twadell, Susan Plaeger, Cathie Spino, Nzeera Ketter, Patricia Uherova, Fred T. Valentine, Victor DeGruttola
Publikováno v:
The Journal of infectious diseases. 182(5)
The potential role of human immunodeficiency virus type 1 (HIV-1)-specific immune responses in controlling viral replication in vivo has stimulated interest in enhancing virus-specific immunity by vaccinating infected individuals with HIV-1 or its co
Autor:
Carl W. White, John E. Repine, Pietro Ghezzi, Marina Bianchi, Mary E. Rosandich, Charles A. Dinarello
Publikováno v:
Cytokine. 3(3)
Exposure to hypoxia (PO2 = 9 +/- 1 torr) increased human peripheral blood mononuclear cell production and secretion of interleukin-1 (IL-1)alpha, IL-1 beta, and tumor necrosis factor (TNF) percent of control = 190% for IL-1 alpha, p = 0.014; 219% for
Publikováno v:
The British journal of dermatology. 118(3)
SUMMARY It has been shown previously by an immunofluorcscence technique, that whole serum from patients who have anti-Ro/SSA autoantibodies reacts with a component or components of the epidermis. We have now demonstrated by immunoblotting that the an